Retatrutide is a next‑generation research peptide widely studied for its unique triple‑agonist activity in advanced metabolic and endocrine research models. This compound is of growing interest in laboratory settings focused on GLP‑1, GIP, and glucagon receptor pathways, making it a valuable tool for researchers exploring complex signaling mechanisms related to energy balance and metabolic regulation.
BlueNexLabs Retatrutide is supplied as a high‑purity, lyophilized research peptide, manufactured under strict quality standards to support reproducibility, stability, and accurate experimental outcomes. Each batch is accompanied by a Certificate of Analysis (COA) verifying identity and purity.
Triple‑agonist peptide targeting GLP‑1, GIP, and glucagon receptors
≥99% purity (verified by third‑party testing)
Supplied in lyophilized powder form for enhanced stability
Designed for in‑vitro, analytical, and laboratory research applications
Batch‑specific Certificate of Analysis included
Peptide Name: Retatrutide
Molecular Weight: ~4119 g/mol
CAS Number: 2759019‑86‑6
Form: Lyophilized powder
Purity: ≥99%
Storage: Refrigerated or frozen prior to reconstitution
Retatrutide is commonly investigated in laboratory environments for:
Peptide–receptor interaction studies
Metabolic signaling pathway research
Stability and degradation analysis
Comparative peptide structure‑function studies
At BlueNexLabs, all peptides are quality‑tested and documented, with a commitment to transparency and consistency. If independent testing demonstrates purity below stated specifications, we offer a refund or replacement guarantee, reinforcing our focus on research integrity.
Retatrutide is a next‑generation research peptide widely studied for its unique triple‑agonist activity in advanced metabolic and endocrine research models. This compound is of growing interest in laboratory settings focused on GLP‑1, GIP, and glucagon receptor pathways, making it a valuable tool for researchers exploring complex signaling mechanisms related to energy balance and metabolic regulation.
BlueNexLabs Retatrutide is supplied as a high‑purity, lyophilized research peptide, manufactured under strict quality standards to support reproducibility, stability, and accurate experimental outcomes. Each batch is accompanied by a Certificate of Analysis (COA) verifying identity and purity.
Triple‑agonist peptide targeting GLP‑1, GIP, and glucagon receptors
≥99% purity (verified by third‑party testing)
Supplied in lyophilized powder form for enhanced stability
Designed for in‑vitro, analytical, and laboratory research applications
Batch‑specific Certificate of Analysis included
Peptide Name: Retatrutide
Molecular Weight: ~4119 g/mol
CAS Number: 2759019‑86‑6
Form: Lyophilized powder
Purity: ≥99%
Storage: Refrigerated or frozen prior to reconstitution
Retatrutide is commonly investigated in laboratory environments for:
Peptide–receptor interaction studies
Metabolic signaling pathway research
Stability and degradation analysis
Comparative peptide structure‑function studies
At BlueNexLabs, all peptides are quality‑tested and documented, with a commitment to transparency and consistency. If independent testing demonstrates purity below stated specifications, we offer a refund or replacement guarantee, reinforcing our focus on research integrity.